Global Primary Aldosteronism Market Research Report 2023

Report ID: 1988845 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Primary Aldosteronism Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Blood Test
        1.2.3 Imaging Test
    1.3 Market by Application
        1.3.1 Global Primary Aldosteronism Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Specialty Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Primary Aldosteronism Market Perspective (2017-2028)
    2.2 Primary Aldosteronism Growth Trends by Region
        2.2.1 Primary Aldosteronism Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Primary Aldosteronism Historic Market Size by Region (2017-2022)
        2.2.3 Primary Aldosteronism Forecasted Market Size by Region (2023-2028)
    2.3 Primary Aldosteronism Market Dynamics
        2.3.1 Primary Aldosteronism Industry Trends
        2.3.2 Primary Aldosteronism Market Drivers
        2.3.3 Primary Aldosteronism Market Challenges
        2.3.4 Primary Aldosteronism Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Primary Aldosteronism Players by Revenue
        3.1.1 Global Top Primary Aldosteronism Players by Revenue (2017-2022)
        3.1.2 Global Primary Aldosteronism Revenue Market Share by Players (2017-2022)
    3.2 Global Primary Aldosteronism Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Primary Aldosteronism Revenue
    3.4 Global Primary Aldosteronism Market Concentration Ratio
        3.4.1 Global Primary Aldosteronism Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Primary Aldosteronism Revenue in 2021
    3.5 Primary Aldosteronism Key Players Head office and Area Served
    3.6 Key Players Primary Aldosteronism Product Solution and Service
    3.7 Date of Enter into Primary Aldosteronism Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Primary Aldosteronism Breakdown Data by Type
    4.1 Global Primary Aldosteronism Historic Market Size by Type (2017-2022)
    4.2 Global Primary Aldosteronism Forecasted Market Size by Type (2023-2028)
5 Primary Aldosteronism Breakdown Data by Application
    5.1 Global Primary Aldosteronism Historic Market Size by Application (2017-2022)
    5.2 Global Primary Aldosteronism Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Primary Aldosteronism Market Size (2017-2028)
    6.2 North America Primary Aldosteronism Market Size by Country (2017-2022)
    6.3 North America Primary Aldosteronism Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Primary Aldosteronism Market Size (2017-2028)
    7.2 Europe Primary Aldosteronism Market Size by Country (2017-2022)
    7.3 Europe Primary Aldosteronism Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Primary Aldosteronism Market Size (2017-2028)
    8.2 Asia-Pacific Primary Aldosteronism Market Size by Country (2017-2022)
    8.3 Asia-Pacific Primary Aldosteronism Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Primary Aldosteronism Market Size (2017-2028)
    9.2 Latin America Primary Aldosteronism Market Size by Country (2017-2022)
    9.3 Latin America Primary Aldosteronism Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Primary Aldosteronism Market Size (2017-2028)
    10.2 Middle East & Africa Primary Aldosteronism Market Size by Country (2017-2022)
    10.3 Middle East & Africa Primary Aldosteronism Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Primary Aldosteronism Introduction
        11.1.4 Pfizer Revenue in Primary Aldosteronism Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Sun Pharmaceutical Industries
        11.2.1 Sun Pharmaceutical Industries Company Detail
        11.2.2 Sun Pharmaceutical Industries Business Overview
        11.2.3 Sun Pharmaceutical Industries Primary Aldosteronism Introduction
        11.2.4 Sun Pharmaceutical Industries Revenue in Primary Aldosteronism Business (2017-2022)
        11.2.5 Sun Pharmaceutical Industries Recent Development
    11.3 Bristol Laboratories
        11.3.1 Bristol Laboratories Company Detail
        11.3.2 Bristol Laboratories Business Overview
        11.3.3 Bristol Laboratories Primary Aldosteronism Introduction
        11.3.4 Bristol Laboratories Revenue in Primary Aldosteronism Business (2017-2022)
        11.3.5 Bristol Laboratories Recent Development
    11.4 CMP Pharma
        11.4.1 CMP Pharma Company Detail
        11.4.2 CMP Pharma Business Overview
        11.4.3 CMP Pharma Primary Aldosteronism Introduction
        11.4.4 CMP Pharma Revenue in Primary Aldosteronism Business (2017-2022)
        11.4.5 CMP Pharma Recent Development
    11.5 Koninklijke Philips
        11.5.1 Koninklijke Philips Company Detail
        11.5.2 Koninklijke Philips Business Overview
        11.5.3 Koninklijke Philips Primary Aldosteronism Introduction
        11.5.4 Koninklijke Philips Revenue in Primary Aldosteronism Business (2017-2022)
        11.5.5 Koninklijke Philips Recent Development
    11.6 GE Healthcare
        11.6.1 GE Healthcare Company Detail
        11.6.2 GE Healthcare Business Overview
        11.6.3 GE Healthcare Primary Aldosteronism Introduction
        11.6.4 GE Healthcare Revenue in Primary Aldosteronism Business (2017-2022)
        11.6.5 GE Healthcare Recent Development
    11.7 Siemens
        11.7.1 Siemens Company Detail
        11.7.2 Siemens Business Overview
        11.7.3 Siemens Primary Aldosteronism Introduction
        11.7.4 Siemens Revenue in Primary Aldosteronism Business (2017-2022)
        11.7.5 Siemens Recent Development
    11.8 Shimadzu Corporation
        11.8.1 Shimadzu Corporation Company Detail
        11.8.2 Shimadzu Corporation Business Overview
        11.8.3 Shimadzu Corporation Primary Aldosteronism Introduction
        11.8.4 Shimadzu Corporation Revenue in Primary Aldosteronism Business (2017-2022)
        11.8.5 Shimadzu Corporation Recent Development
    11.9 Canon
        11.9.1 Canon Company Detail
        11.9.2 Canon Business Overview
        11.9.3 Canon Primary Aldosteronism Introduction
        11.9.4 Canon Revenue in Primary Aldosteronism Business (2017-2022)
        11.9.5 Canon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Primary Aldosteronism Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Blood Test
    Table 3. Key Players of Imaging Test
    Table 4. Global Primary Aldosteronism Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Primary Aldosteronism Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Primary Aldosteronism Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Primary Aldosteronism Market Share by Region (2017-2022)
    Table 8. Global Primary Aldosteronism Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Primary Aldosteronism Market Share by Region (2023-2028)
    Table 10. Primary Aldosteronism Market Trends
    Table 11. Primary Aldosteronism Market Drivers
    Table 12. Primary Aldosteronism Market Challenges
    Table 13. Primary Aldosteronism Market Restraints
    Table 14. Global Primary Aldosteronism Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Primary Aldosteronism Market Share by Players (2017-2022)
    Table 16. Global Top Primary Aldosteronism Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Aldosteronism as of 2021)
    Table 17. Ranking of Global Top Primary Aldosteronism Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Primary Aldosteronism Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Primary Aldosteronism Product Solution and Service
    Table 21. Date of Enter into Primary Aldosteronism Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Primary Aldosteronism Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Primary Aldosteronism Revenue Market Share by Type (2017-2022)
    Table 25. Global Primary Aldosteronism Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Primary Aldosteronism Revenue Market Share by Type (2023-2028)
    Table 27. Global Primary Aldosteronism Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Primary Aldosteronism Revenue Market Share by Application (2017-2022)
    Table 29. Global Primary Aldosteronism Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Primary Aldosteronism Revenue Market Share by Application (2023-2028)
    Table 31. North America Primary Aldosteronism Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Primary Aldosteronism Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Primary Aldosteronism Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Primary Aldosteronism Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Primary Aldosteronism Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Primary Aldosteronism Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Primary Aldosteronism Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Primary Aldosteronism Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Primary Aldosteronism Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Primary Aldosteronism Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Pfizer Company Detail
    Table 42. Pfizer Business Overview
    Table 43. Pfizer Primary Aldosteronism Product
    Table 44. Pfizer Revenue in Primary Aldosteronism Business (2017-2022) & (US$ Million)
    Table 45. Pfizer Recent Development
    Table 46. Sun Pharmaceutical Industries Company Detail
    Table 47. Sun Pharmaceutical Industries Business Overview
    Table 48. Sun Pharmaceutical Industries Primary Aldosteronism Product
    Table 49. Sun Pharmaceutical Industries Revenue in Primary Aldosteronism Business (2017-2022) & (US$ Million)
    Table 50. Sun Pharmaceutical Industries Recent Development
    Table 51. Bristol Laboratories Company Detail
    Table 52. Bristol Laboratories Business Overview
    Table 53. Bristol Laboratories Primary Aldosteronism Product
    Table 54. Bristol Laboratories Revenue in Primary Aldosteronism Business (2017-2022) & (US$ Million)
    Table 55. Bristol Laboratories Recent Development
    Table 56. CMP Pharma Company Detail
    Table 57. CMP Pharma Business Overview
    Table 58. CMP Pharma Primary Aldosteronism Product
    Table 59. CMP Pharma Revenue in Primary Aldosteronism Business (2017-2022) & (US$ Million)
    Table 60. CMP Pharma Recent Development
    Table 61. Koninklijke Philips Company Detail
    Table 62. Koninklijke Philips Business Overview
    Table 63. Koninklijke Philips Primary Aldosteronism Product
    Table 64. Koninklijke Philips Revenue in Primary Aldosteronism Business (2017-2022) & (US$ Million)
    Table 65. Koninklijke Philips Recent Development
    Table 66. GE Healthcare Company Detail
    Table 67. GE Healthcare Business Overview
    Table 68. GE Healthcare Primary Aldosteronism Product
    Table 69. GE Healthcare Revenue in Primary Aldosteronism Business (2017-2022) & (US$ Million)
    Table 70. GE Healthcare Recent Development
    Table 71. Siemens Company Detail
    Table 72. Siemens Business Overview
    Table 73. Siemens Primary Aldosteronism Product
    Table 74. Siemens Revenue in Primary Aldosteronism Business (2017-2022) & (US$ Million)
    Table 75. Siemens Recent Development
    Table 76. Shimadzu Corporation Company Detail
    Table 77. Shimadzu Corporation Business Overview
    Table 78. Shimadzu Corporation Primary Aldosteronism Product
    Table 79. Shimadzu Corporation Revenue in Primary Aldosteronism Business (2017-2022) & (US$ Million)
    Table 80. Shimadzu Corporation Recent Development
    Table 81. Canon Company Detail
    Table 82. Canon Business Overview
    Table 83. Canon Primary Aldosteronism Product
    Table 84. Canon Revenue in Primary Aldosteronism Business (2017-2022) & (US$ Million)
    Table 85. Canon Recent Development
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Primary Aldosteronism Market Share by Type: 2021 VS 2028
    Figure 2. Blood Test Features
    Figure 3. Imaging Test Features
    Figure 4. Global Primary Aldosteronism Market Share by Application in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Specialty Clinic Case Studies
    Figure 7. Others Case Studies
    Figure 8. Primary Aldosteronism Report Years Considered
    Figure 9. Global Primary Aldosteronism Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Primary Aldosteronism Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Primary Aldosteronism Market Share by Region: 2021 VS 2028
    Figure 12. Global Primary Aldosteronism Market Share by Players in 2021
    Figure 13. Global Top Primary Aldosteronism Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Aldosteronism as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Primary Aldosteronism Revenue in 2021
    Figure 15. North America Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Primary Aldosteronism Market Share by Country (2017-2028)
    Figure 17. United States Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Primary Aldosteronism Market Share by Country (2017-2028)
    Figure 21. Germany Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Primary Aldosteronism Market Share by Region (2017-2028)
    Figure 29. China Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Primary Aldosteronism Market Share by Country (2017-2028)
    Figure 37. Mexico Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Primary Aldosteronism Market Share by Country (2017-2028)
    Figure 41. Turkey Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Primary Aldosteronism Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Pfizer Revenue Growth Rate in Primary Aldosteronism Business (2017-2022)
    Figure 44. Sun Pharmaceutical Industries Revenue Growth Rate in Primary Aldosteronism Business (2017-2022)
    Figure 45. Bristol Laboratories Revenue Growth Rate in Primary Aldosteronism Business (2017-2022)
    Figure 46. CMP Pharma Revenue Growth Rate in Primary Aldosteronism Business (2017-2022)
    Figure 47. Koninklijke Philips Revenue Growth Rate in Primary Aldosteronism Business (2017-2022)
    Figure 48. GE Healthcare Revenue Growth Rate in Primary Aldosteronism Business (2017-2022)
    Figure 49. Siemens Revenue Growth Rate in Primary Aldosteronism Business (2017-2022)
    Figure 50. Shimadzu Corporation Revenue Growth Rate in Primary Aldosteronism Business (2017-2022)
    Figure 51. Canon Revenue Growth Rate in Primary Aldosteronism Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Sun Pharmaceutical Industries
Bristol Laboratories
CMP Pharma
Koninklijke Philips
GE Healthcare
Siemens
Shimadzu Corporation
Canon
Frequently Asked Questions
Primary Aldosteronism report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Primary Aldosteronism report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Primary Aldosteronism report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Transportation

Transportation market is segmented by players, region (country), by Type and by Application. Play ... Read More

Warehouse

Warehouse market is segmented by players, region (country), by Type and by Application. Players,  ... Read More

Wireless

Wireless market is segmented by players, region (country), by Type and by Application. Players, s ... Read More